The 2022 conference of the American Association for the Treatment of Opioid Dependence is coming up soon, and AT Forum will be there to report on all the news. Sponsors of the conference are listed below.
Centers for Medicare & Medicaid Services
The meeting, which starts October 30 and ends November 3, has as its goals:
- To discuss the latest research and regulatory developments relevant to the field of medication-assisted treatment and critically evaluate the implications in managing the opioid epidemic;
- To disseminate innovative and evidence-based initiatives designed to increase access to services, improve program development and administration, and enhance patient outcomes;
- To strategize approaches to promote, support, facilitate, and integrate medication-assisted treatment into the judicial and penal systems, government, social service organizations, and mainstream medicine;
- To identify and promote strategies that assist healthcare partnerships and collaborations by advancing understanding and acceptance of medication-assisted treatment as a crucial element to community wellness and response to the opioid epidemic; and
- To address and refute misinformation and stigma and promote acceptance of comprehensive medication-assisted treatment throughout the continuum of care.
The hosts of the 2022 meeting, “The Power of Collaboration,” are the Opioid Treatment Providers of Maryland and the Maryland Department of Health — Behavioral Health Administration. The meeting will have an opening from Rahul Gupta, MD, Director of the White House Office of National Drug Control Policy (ONDCP) and will conclude with a presentation from Miriam E. Delphin-Rittmon, Ph.D., the HHS Assistant Secretary for Mental Health and Substance Use and the leader of the Substance Abuse and Mental Health Services Administration (SAMHSA).
“Our nation continues to face the deadly public health challenge of opioid use disorder, especially driven by fentanyl, which accounts for more than 65% of reported mortality rates,” said Mark Parrino, M.P.A., President of AATOD. “We are increasing access to opioid treatment programs throughout the United States in addition to increasing the use of mobile treatment vans and brick and mortar medication units. It is important to draw upon evidence when increasing access to good quality and well-coordinated care and these will be featured topics during our Conference. We also need to develop a public education campaign about opioid use disorder and its effective treatment.”
The AATOD Conference is the largest gathering of the opioid treatment community. This conference comes at a critical time for the U.S. and Baltimore, in particular, which is home to one of the first OTPs in the country, Man Alive/Lane Treatment Center, and has expanded its treatment network to nearly 40 OTPs over the past 50 years as the need for effective OUD treatment has grown. This includes a mix of freestanding, hospital and justice-based facilities, as well as for- and not-for-profit programs. During the proceedings, the World Federation for the Treatment of Opioid Dependence, of which AATOD is a member, will also convene a major meeting on Monday, October 31, 2022.
“Now more than ever, with highly potent opioids on the streets, and with increasing social and mental health problems in part stemming from the COVID pandemic and economic struggles, people with opioid use disorder need comprehensive treatment to fully recover,” said Kenneth B. Stoller, MD, DLFAPA, Associate Professor, Johns Hopkins University School of Medicine and Conference Chair. “This requires a collaborative approach. The gathering in Baltimore, a stone’s throw from our federal oversight partners, is an opportunity for treatment providers, related fields such as social services and criminal justice, and policymakers, to learn together and forge productive connections.”
“Maryland Department of Health is committed to increasing access to evidence-based harm reduction and treatment practices, including the use of effective medications, to help address the opioid crisis,” said Kathleen Rebbert-Franklin, Director of Service Access and Practice Innovation for the Maryland Department of Health’s Behavioral Health Administration. “This conference offers providers from many service settings the most current research and treatment information that will further enhance their practices and improve care in Maryland.”
Featured speakers will include:
- Tuesday, November 1 — Robin E. Rickard, JD, Executive Director, Opioid Operational Command Center, Crownsville, MD; Mark W. Parrino, MPA, President, AATOD; Rahul Gupta, MD, MPH, MBA, FACP, Director of the White House Office of National Drug Control Policy (ONDCP). Moderated by Kenneth B. Stoller, MD, DLFAPA, Director, Johns Hopkins Broadway Center for Addiction; Associate Professor, Department of Psychiatry, Johns Hopkins University School of Medicine.
- Wednesday, November 2 — Kathleen Rebbert-Franklin, LCSW-C, Director, Service Access and Practice Innovation, Maryland Department of Health, Behavioral Health Administration, Catonsville, MD; Babak Imanoel, DO, Medical Director, Northern Parkway Treatment Services, Baltimore, MD; Gregory Branch, MD, MBA, CPE, Health Officer and Director, Baltimore, MD. Moderated by Vickie Walters, LCSW-C, Executive Director, Institutes for Behavior Resources, Inc, Baltimore, MD.
- Thursday, November 3 — Miriam E. Delphin-Rittmon, Ph.D., the HHS Assistant Secretary for Mental Health and Substance Use and the leader of the Substance Abuse and Mental Health Services Administration (SAMHSA). Moderated by Mark Parrino/AATOD.